Teladoc Health logo

Teladoc Health (TDOC) Q3 2024 Earnings

TDOC·Reported October 30, 2024·After market close

Teladoc Health reported Q3 2024 revenue of $640.5M, beat analyst consensus of $640.4M by $84.1K. Diluted EPS came in at $-0.19, beat the $-0.29 consensus by $0.10.

Revenue
$640.5Mbeat by $84.1K
Consensus: $640.4M
Diluted EPS
$-0.19beat by $0.10
Consensus: $-0.29
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Teladoc Health's Q3 2024 earnings report.

Teladoc Health (TDOC) reported Q3 2024 earnings on October 30, 2024 after market close.

Teladoc Health reported revenue of $640.5M and diluted EPS of $-0.19 for Q3 2024.

Revenue beat the consensus estimate of $640.4M by $84.1K. EPS beat the consensus estimate of $-0.29 by $0.10.

You can read the 10-Q periodic report (0001477449-24-000225) directly on SEC EDGAR. The filing index links above go to sec.gov.